AI enhances breast cancer care by improving mammography accuracy, reducing false negatives, and aiding in clinical trial enrollment and design. AI-driven digital patient profiling reduces placebo use ...
Ochsner Health, in partnership with MD Anderson, has established multiple cancer centers throughout the state of Louisiana, ...
The University of Texas MD Anderson Cancer Center today launches its historic $2.5 billion comprehensive philanthropic campaign, Only Possible Here, The Campaign to End Cancer.
The FDA on Nov. 11 appointed Richard Pazdur, MD, as the new director of the Center for Drug Evaluation and Research.Pazdur ...
TULSA, Okla. — The OU Health Stephenson Cancer Center broke ground on a major expansion in Tulsa on Thursday. The new 176,000 ...
Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...
PermitUsNow, a division of Bradlink LLC and a statewide leader in building permitting solutions for architects, contractors, and project owners, proudly announces its role as a Silver Sponsor of the ...
University of Texas MD Anderson Cancer Center announces $2.5 billion 'Only Possible Here, Campaign to End Cancer' at event in ...
Today, Fred Hutch announced that in 2025 the Obliteride community raised $9.2 million for groundbreaking research. This amount brings Obliteride’s cumulative fundraising total to more than $67 million ...
PDS Biotechnology Corp (PDSB) reports promising trial results and strategic collaborations, despite financial hurdles and trial amendments.
(Alliance News) - Imaging Biometrics Ltd on Thursday noted the use of its Functional Tumor Burden mapping technology in a glioblastoma clinical trial at Cooper University's MD Anderson Cancer Center.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback